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Abstract
Background: Reporting new cases of enterovirus (EV)-D68-associated acute flaccid myelitis (AFM) is essential to
understand how the virus causes neurological damage and to characterize EV-D68 strains associated with AFM.
Case presentation: A previously healthy 4-year-old boy presented with sudden weakness and limited mobility in his left
arm. Two days earlier, he had an upper respiratory illness with mild fever. At admission, his physical examination showed
that the child was febrile (38.5 °C) and alert but had a stiff neck and weakness in his left arm, which was hypotonic and
areflexic. Cerebrospinal fluid (CSF) examination showed a mild increase in white blood cell count (80/mm3, 41%
neutrophils) and a slightly elevated protein concentration (76 gm/dL). Bacterial culture and molecular biology tests for
detecting viral infection in CSF were negative. The patient was then treated with intravenous ceftriaxone and acyclovir.
Despite therapy, within 24 h, the muscle weakness extended to all four limbs, which exhibited greatly reduced mobility.
Due to his worsening clinical prognosis, the child was transferred to our Pediatric Intensive Care Unit; at admission he was
diagnosed with acute flaccid paralysis of all four limbs. Brain magnetic resonance imaging (MRI) was negative, except for
a focal signal alteration in the dorsal portion of the medulla oblongata, also involving the pontine tegmentum, whereas
spine MRI showed an extensive signal alteration of the cervical and dorsal spinal cord reported as myelitis. Signal
alteration was mainly localized in the central grey matter, most likely in the anterior horns. Molecular biology tests
performed on nasopharyngeal aspirate and on bronchoalveolar lavage fluid were negative for bacteria but positive for
EV-D68 clade B3. Plasmapheresis was performed and corticosteroids and intravenous immunoglobulins were
administered. After 4 weeks of treatment, the signs and symptoms of AFM were significantly reduced, although some
weakness and tingling remained in the patient’s four limbs. MRI acquired after 3 weeks showed that the previously
reported alterations were no longer present.
Conclusion: This case suggests that EV-D68 is a neurotropic agent that can cause AFM and strains are circulating in
Europe. EV-D68 disease surveillance is required to better understand EV-D68 pathology and to compare various strains
that cause AFM.
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Background
Until 2013, enterovirus (EV)-D68 was considered a rare
cause of disease because only sporadic cases and minor
outbreaks of respiratory infection occurred. However,
since 2014, EV-D68 infection has gained epidemiological
and clinical relevance when the virus caused a large-scale
outbreak of severe respiratory infections, mainly in
children, in the USA and Canada, with subsequent cases
in other countries [1–3]. Respiratory disorders due to EV-
D68 varied from pharyngitis and bronchitis to severe
pneumonia with respiratory failure [4]. Additionally, con-
comitant with EV-D68-associated respiratory disease in
the USA, there was an increase in the number of cases of
severe neurological disease, mainly acute flaccid myelitis
(AFM) [5]. EV-D68 was not detected in the cerebrospinal
fluid (CSF) of these patients, and therefore definitive
causation between EV-D68 and AFM was not established.
However, the possibility of EV-D68 causing a polio-like
disease was still considered. Other EVs, specifically EV-
A71, are well known neurotropic agents that can cause
aseptic meningitis, meningoencephalitis, and AFM [6].
Moreover, EV-D68 was detected in the respiratory secre-
tions of several of the AFM cases diagnosed during the
2014 outbreak in the USA [5]. Finally, a case-control study
of the presence of EV-D68 in upper respiratory secretions
of children with acute respiratory infection demonstrated
that children with infection and AFM were 10.3 times
more likely to be infected with EV-D68 than children
without AFM tested for respiratory infections [7]. Very
few EV-D68-associated AFM cases have been reported in
Europe [8–12]. Reporting new cases of this disease is
essential to better understand how EV-D68 causes neuro-
logical damage and to identify and characterize the strains
associated with AFM. In this paper, a case of AFM associ-
ated with EV-D68 infection occurring in an otherwise
healthy child in Milan, Italy, is described.
Case presentation
A previously healthy, fully immunized, 4-year-old boy came
to the Emergency Room of the Saint Anna Hospital in Como
on July 21, 2016, presenting with sudden onset weakness
and poor mobility in his left arm. Two days earlier, he had
an upper respiratory illness with mild fever, rhinorrhoea, and
cough. Past and recent clinical histories were negative for
relevant diseases. At admission, physical examination of the
patient showed that the child had a temperature of 38.5 °C, a
heart rate of 131/min, a respiratory rate of 18/min, 98%
oxygen saturation and a blood pressure of 110/70 mmHg.
Respiratory, cardiovascular, and skin examinations were nor-
mal. Neurological evaluation demonstrated that the child
was alert but had a stiff neck and weakness in his left arm,
which was hypotonic and areflexic. The results of cranial
nerve examination, including fundoscopy, and diagnoses of
the right arm and bilateral leg strength were normal.
Results from a complete blood count were in the normal
range, with the exception of slightly elevated white blood
cell and neutrophil counts. Serum electrolytes, coagulation
factors, liver enzymes, and C-reactive protein were within
the normal limits. Fine bilateral perihilar infiltration was
observed on a chest X-ray to give the diagnosis of prob-
able community-acquired pneumonia of viral aetiology.
CSF examination showed a mild increase in white blood
cell count (80/mm3, 41% neutrophils) with normal glucose
(60 mg/dL) and slightly elevated protein (76 gm/dL)
concentrations. Cultures for bacteria were negative, and
molecular biology tests for detecting viral infection were
negative for herpes simplex virus 1, herpes simplex virus 2,
human herpesvirus 6, EV, varicella zoster virus, adenovirus,
parvovirus, cytomegalovirus, and Epstein-Barr virus.
Computed tomography of the head without contrast did
not show abnormalities. Intravenous ceftriaxone and
acyclovir were then administered.
Despite this therapy, the child’s neurological function
deteriorated rapidly. Within 24 h, the muscle weakness ex-
tended to all four limbs, which exhibited greatly reduced
mobility. Due to his worsening clinical prognosis, the child
was transferred to the Pediatric Intensive Care Unit (PICU)
of the Fondazione IRCCS Ca’ Granda, Ospedale Maggiore
Policlinico, Milan, Italy.
When the child was admitted to the PICU on July 22,
2016, he was alert but was diagnosed with acute flaccid par-
alysis based on neurological examination. Together with the
muscles of the four limbs, the respiratory muscles were also
clearly involved. Moreover, a deficit of the right facial nerve
with dysphagia was observed. The child required intubation
and mechanical ventilation for adequate gas exchange. After
11 days, tracheotomy was performed. Nutrition was assured
through percutaneous endoscopic gastrotomy.
Figure 1a–d summarizes the results of magnetic reson-
ance imaging (MRI) of the brain at admission to the
PICU, 3 days and about 24 h after the onset of respira-
tory and neurological manifestations, respectively. A
focal signal alteration was found localized in the dorsal por-
tion of the medulla oblongata, also involving the pontine
tegmentum, without enhancement or diffusion restriction.
Moreover, MRI of the spinal cord showed an extensive
signal alteration of the cervical and dorsal spinal cord, re-
ported as myelitis. The signal alteration was mainly local-
ized in the central grey matter, most likely in the anterior
horns. After contrast administration, a slight enhancement
in some of the caudal roots was observed, without en-
hancement in the spinal cord.
The presence of somatosensory-evoked potentials con-
firmed that only the motor pathway was affected. Acute
polyradiculoneuritis was excluded because there was no
albumino-cytological dissociation and no antiganglioside
antibodies in the CSF. There was no evidence of paraneo-
plasic syndrome or inflammatory disease.
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Bacterial cultures of the nasopharyngeal aspirate and the
bronchoalveolar lavage fluid were negative. Molecular
biology tests for detecting viral infection were negative for
herpes simplex virus 1, herpes simplex virus 2, human her-
pesvirus 6, varicella zoster virus, adenovirus, parvovirus,
cytomegalovirus and EBV, but was positive for EV. Both the
respiratory samples were reanalysed for the presence of EV-
D68 using single-tube real-time PCR to amplify a 116 bp
fragment of the 5′ non-translated region according to the
method proposed by Poelman et al. [13]. Phylogenetic ana-
lysis based on the method used by Nix et al. [14] verified
the presence of a virus belonging to clade B3 of the EV-
D68 phylogenetic tree (Fig. 2). Sequence analysis showed
that the 2016 strains were closely related to sequences of
the recently described subclade B3, represented in Fig. 2, by
four sequences obtained in China. The level of nucleotide
divergence was 2.1% within B3, 5.5% between B1 and B3,
and 7.3% between B2 and B3. The sequence from our
Italian AFM case was closely related to Dutch AFM EV-
D68 cases from 2016.
Serological analysis showed no infection with herpes
simplex virus, varicella zoster virus, Epstein-Barr virus,
cytomegalovirus, Mycoplasma pneumoniae, Borrelia
burgdorferi, Cryptococcus neoformans, or Mycobacterium
tuberculosis.
Treatment with intravenous methylprednisolone (30 mg/
kg) was initiated. Plasmapheresis was conducted and intra-
venous immunoglobulins (1 g/kg/day) were administered
during the first 3 days in the PICU. Intravenous steroid
therapy was suspended after 5 days and substituted with
oral prednisone (2 mg/kg/day) for 4 weeks, which was then
tapered over an additional 2 weeks.
Significant weakness with reduced mobility of the four
limbs and difficulty swallowing persisted with very slow re-
gression. After 4 weeks of treatment, all the signs and symp-
toms of AFM were significantly reduced or disappeared,
although a certain degree of weakness and tingling in the
four extremities were still present. Moreover, deep tendon
reflexes were generally reduced. However, as expected due
to the recent onset of the disease, no muscle atrophy was
observed. Moreover, the results of MRI performed about
1 month after the onset of the first neurological manifesta-
tions showed that the previously reported alterations were
no longer present (Fig. 1e).
Conclusions
AFM is a rare disease in polio-free geographical areas. Most
of the cases are due to EVs, mainly EV-A71, flaviviruses,
Japanese encephalitis virus, and West Nile virus [15, 16].
Recently, several AFM cases were diagnosed during an
Fig. 1 Magnetic resonance imaging (MRI) of the brain and spinal cord: a, axial T2 image at the level of the pons showing an increased signal in
the tegmentum (white arrows), which was completely resolved in the follow up scan acquired 3 weeks later; b, sagittal and axial T2 image of the
spinal cord (c, d) showing cord swelling, particularly at the cervical level (white, dot arrow), with extensive hyperintensity in the central cord (d),
which was also completely resolved in the follow up images (e) acquired 3 weeks later
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outbreak of EV-D68 respiratory infection, indicating an as-
sociation between AFM and EV-D68 infection, although a
direct causative role has not been established [3, 5]. How-
ever, EV-D68 has been detected in the cerebrospinal fluid
of two patients with AFM [3, 5, 15, 17] and, more recently,
in two other patients with aseptic meningitis [18].
The case described here suggests that EV-D68 is a
neurotropic agent that can cause AFP. The case of AFM
described here clinically resembles those described in the
USA and Canada since 2014 [7] and the few cases
described later in Europe [16]. AFM was diagnosed in a
child suffering from a mild acute respiratory infection,
who was febrile at the onset of neurological symptoms.
Moreover, the pattern of neurological deficits and neuro-
imaging abnormalities localizing to the anterior horn cells
of the spinal cord and cranial nerve motor nuclei in the
brainstem are similar to those observed in other patients
with AFM. Finally, CSF examination revealed alterations
suggestive of aseptic meningitis. Together with these find-
ings, the presence of EV-D68 in both the nasopharyngeal
aspirate and BAL of the patient suggests a relationship
between AFM and EV-D68, particularly because no other
infection of the central nervous system could be found.
The inability to detect EV-D68 in the CSF does not greatly
weaken this relationship because an inability to detect an
infectious agent in the central nervous system of patients
with neurological complications from neurotropic viruses,
including polio and EV-A71, is common [6]. A progressive
reduction in signs and symptoms of disease occurred,
albeit slowly, in the child described here, and MRI per-
formed approximately 1 month after the onset of disease
did not show persistent alterations. Although electromyo-
gram and nerve conduction studies better correlate than
MRI with final prognosis of AFM, this result suggests that
this case could have a favourable prognosis, with long-
term resolution of the neurological problems.
However, some reported cases have a less favourable
outcome. Two children with EV-D68-associated AFM in
Norway were recently described as having persistent defi-
cits [8]. One had impaired head and motor control in his
arm and the second developed atrophy in the left upper
arm and shoulder. Thus, neurological damage due to EV-
D68 infection can be severe and persistent, in a similar
manner to polio infection and infection with other known
neurotropic viruses.
The EV-D68 strain detected in this study was found to
belong to the B3 clade. Despite all three clades of EV-D68
having been found to circulate worldwide, most of the
cases detected in the USA [19] and Europe [3, 20] were
from genetically similar viruses of clade B. Data regarding
strains associated with the development of AFM are
scarce. However, strains identified in the USA [16] were
found to differ from other clade B strains in six amino acid
substitutions, three of which are found in the structural
and nonstructural proteins, thereby further defining the
B1 clade. This finding led to the hypothesis that these
strains could be significantly more neurotropic and viru-
lent than other EV-D68 strains and that sequence data of
the infecting strain could predict the clinical manifesta-
tions and outcomes of EV-D68 infection [21]. Our case re-
port did not support this hypothesis and indicates that
sequence data cannot predict clinical outcome. However,
although characterization of EV-D68 is usually based on
sequencing the VP1 region, mutations in other regions
might confer higher virulence and increased risk of neuro-
logical complications during infection with certain EV-
D68 strains. EV-D68 disease surveillance is warranted to
clarify any potential differences in strain virulence and to
define the pathogenic role of infection as a cause of AFM.
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